{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:35:25Z","timestamp":1787319325446,"version":"build-2736575974"},"reference-count":43,"publisher":"PeerJ","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Center of Excellence in Medical Biotechnology","award":["No. SB-61-004-02"],"award-info":[{"award-number":["No. SB-61-004-02"]}]},{"DOI":"10.13039\/501100009037","name":"SATREPS","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009037","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Dengue is a mosquito-borne disease caused by four dengue virus serotypes (DENV1 to DENV4). Secondary infections can generate flavivirus cross-reactive antibodies at sub-neutralizing levels. This phenomenon can significantly increase the severity of secondary infections through antibody-dependent enhancement (ADE). ADE is associated with a high risk of viral infection in immune effector cells, triggering cytokine cascades and activating the complement system, which can lead to severe symptoms. Despite extensive studies, therapeutic antibodies, particularly fully human monoclonal antibodies, which could serve as candidates for immune passive therapy, have not yet been discovered.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methodology<\/jats:title>\n                    <jats:p>\n                      This study generated LALA-mutated human monoclonal antibody clone B3B9 (LALA-B3B9 HuMAb) which can neutralize all four DENV serotypes without enhancing viral activity. The number of infected cells in the ADE assay was compared among the wild-type antibody (B3B9), LALA-B3B9 HuMAb, and an Fc modified variant at position N297Q (N297Q-B3B9), with or without complement proteins. Moreover, the therapeutic efficacy of these HuMAbs against ADE infection by competing with natural antibodies in patients with acute dengue was evaluated using the\n                      <jats:italic>in vitro<\/jats:italic>\n                      suppression-of-enhancement assay in K562 cells.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>\n                      Our novel Fc-modified antibody LALA-B3B9 (Leu234Ala\/Leu235Ala mutations), exhibited neutralizing activity against all dengue virus serotypes without triggering ADE activity at any antibody concentration. This outcome was similar to that observed with the previously developed Fc-modified N297Q-B3B9 antibody (N297Q mutation). We further evaluated the effect of complement protein on the enhancing and neutralizing activities of our Fc-modified antibodies. The results showed that LALA-B3B9 and N297Q-B3B9 HuMAbs were complement-independent, meaning that the reduced binding between complement protein (C1q) and the Fc portion of the antibody left the neutralizing and enhancing activities unchanged. Additionally, both LALA-B3B9 and N297Q-B3B9 HuMAbs demonstrated the suppression-of-enhancement activity in K562 cells induced by human anti-DENV serum antibodies. Overall, this study highlights the main advantages of our EDII-specific HuMAbs in inhibiting\n                      <jats:italic>in vitro<\/jats:italic>\n                      ADE, indicating that they are promising candidates for future dengue treatment.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.7717\/peerj.20329","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T08:24:22Z","timestamp":1763540662000},"page":"e20329","source":"Crossref","is-referenced-by-count":2,"title":["Dissecting antibody-dependent enhancement modulation by Fc-modified cross-neutralizing human monoclonal antibody"],"prefix":"10.7717","volume":"13","author":[{"given":"Subenya","family":"Injampa","sequence":"first","affiliation":[{"name":"Faculty of Medicine, King Mongkut\u2019s Institute of Technology, Ladkrabang, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surachet","family":"Benjathummarak","sequence":"additional","affiliation":[{"name":"Center of Excellence for Antibody Research, Faculty of Tropical Medicine, Mahidol University, Bangkok,  Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujitra","family":"Keadsanti","sequence":"additional","affiliation":[{"name":"Center of Excellence for Antibody Research, Faculty of Tropical Medicine, Mahidol University, Bangkok,  Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rochanawan","family":"Sootichote","sequence":"additional","affiliation":[{"name":"Center of Excellence for Antibody Research, Faculty of Tropical Medicine, Mahidol University, Bangkok,  Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilarat","family":"Puangmanee","sequence":"additional","affiliation":[{"name":"Department of Social and Environmental Medicine, Faculty of Tropical Medicine, Mahidol University,  Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Yamanaka","sequence":"additional","affiliation":[{"name":"Research Institute for Microbial Diseases, Osaka University, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadahiro","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Department of Viral Infections, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pongrama","family":"Ramasoota","sequence":"additional","affiliation":[{"name":"Center of Excellence for Antibody Research, Faculty of Tropical Medicine, Mahidol University, Bangkok,  Thailand"},{"name":"Department of Social and Environmental Medicine, Faculty of Tropical Medicine, Mahidol University,  Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pannamthip","family":"Pitaksajjakul","sequence":"additional","affiliation":[{"name":"Center of Excellence for Antibody Research, Faculty of Tropical Medicine, Mahidol University, Bangkok,  Thailand"},{"name":"Department of Social and Environmental Medicine, Faculty of Tropical Medicine, Mahidol University,  Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4443","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"issue":"10","key":"10.7717\/peerj.20329\/ref-1","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.3390\/pharmaceutics15102402","article-title":"Fc-engineered therapeutic antibodies: recent advances and future directions","volume":"15","author":"Abdeldaim","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.7717\/peerj.20329\/ref-2","doi-asserted-by":"publisher","first-page":"3942","DOI":"10.1002\/jps.23730","article-title":"High-throughput biophysical analysis and data visualization of conformational stability of an IgG1 monoclonal antibody after deglycosylation","volume":"102","author":"Alsenaidy","year":"2013","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.7717\/peerj.20329\/ref-3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00430-021-00726-1","article-title":"Discovery of B-cell epitopes for development of dengue vaccines and antibody therapeutics","volume":"211","author":"Anasir","year":"2022","journal-title":"Medical Microbiology and Immunology"},{"key":"10.7717\/peerj.20329\/ref-4","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.molimm.2014.09.017","article-title":"Highly reduced binding to high and low affinity mouse Fc gamma receptors by L234A\/L235A and N297A Fc mutations engineered into mouse IgG2a","volume":"63","author":"Arduin","year":"2015","journal-title":"Molecular Immunology"},{"key":"10.7717\/peerj.20329\/ref-5","doi-asserted-by":"publisher","first-page":"e1000790","DOI":"10.1371\/journal.ppat.1000790","article-title":"Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification","volume":"6","author":"Balsitis","year":"2010","journal-title":"PLOS Pathogens"},{"key":"10.7717\/peerj.20329\/ref-6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.chom.2010.08.007","article-title":"The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity","volume":"8","author":"Beltramello","year":"2010","journal-title":"Cell Host & Microbe"},{"key":"10.7717\/peerj.20329\/ref-7","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.ijid.2020.12.039","article-title":"Role of the complement system in antibody-dependent enhancement of flavivirus infections","volume":"103","author":"Byrne","year":"2021","journal-title":"International Journal of Infectious Diseases"},{"key":"10.7717\/peerj.20329\/ref-8","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1128\/JVI.02273-12","article-title":"Mechanistic study of broadly neutralizing human monoclonal antibodies against dengue virus that target the fusion loop","volume":"87","author":"Costin","year":"2013","journal-title":"Journal of Virology"},{"key":"10.7717\/peerj.20329\/ref-9","doi-asserted-by":"publisher","first-page":"13975","DOI":"10.1128\/JVI.78.24.13975-13986.2004","article-title":"Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes","volume":"78","author":"Crill","year":"2004","journal-title":"Journal of Virology"},{"key":"10.7717\/peerj.20329\/ref-10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.2174\/1875397300903010022","article-title":"HTRF: a technology tailored for drug discovery\u2014a review of theoretical aspects and recent applications","volume":"3","author":"Degorce","year":"2009","journal-title":"Current Chemical Genomics"},{"key":"10.7717\/peerj.20329\/ref-11","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/ni.3058","article-title":"A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus","volume":"16","author":"Dejnirattisai","year":"2015","journal-title":"Nature Immunology"},{"key":"10.7717\/peerj.20329\/ref-12","doi-asserted-by":"publisher","first-page":"e16059","DOI":"10.1371\/journal.pone.0016059","article-title":"A broadly flavivirus cross-neutralizing monoclonal antibody that recognizes a novel epitope within the fusion loop of E protein","volume":"6","author":"Deng","year":"2011","journal-title":"PLOS ONE"},{"key":"10.7717\/peerj.20329\/ref-13","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.virusres.2013.11.007","article-title":"C1q binding to dengue virus decreases levels of infection and inflammatory molecules transcription in THP-1 cells","volume":"179","author":"Douradinha","year":"2014","journal-title":"Virus Research"},{"key":"10.7717\/peerj.20329\/ref-14","doi-asserted-by":"publisher","first-page":"7232","DOI":"10.1128\/JVI.69.11.7232-7243.1995","article-title":"Evidence that flavivirus NS1-NS2A cleavage is mediated by a membrane-bound host protease in the endoplasmic reticulum","volume":"69","author":"Falgout","year":"1995","journal-title":"Journal of Virology"},{"key":"10.7717\/peerj.20329\/ref-15","doi-asserted-by":"publisher","first-page":"e1009331","DOI":"10.1371\/journal.ppat.1009331","article-title":"Antibody affinity versus dengue morphology influences neutralization","volume":"17","author":"Fibriansah","year":"2021","journal-title":"PLOS Pathogens"},{"key":"10.7717\/peerj.20329\/ref-16","doi-asserted-by":"publisher","first-page":"e0008602","DOI":"10.1371\/journal.pntd.0008602","article-title":"A complement component C1q-mediated mechanism of antibody-dependent enhancement of Ebola virus infection","volume":"14","author":"Furuyama","year":"2020","journal-title":"PLOS Neglected Tropical Diseases"},{"key":"10.7717\/peerj.20329\/ref-17","doi-asserted-by":"publisher","first-page":"929895","DOI":"10.3389\/fimmu.2022.929895","article-title":"Role of Fc core fucosylation in the effector function of IgG1 antibodies","volume":"13","author":"Golay","year":"2022","journal-title":"Frontiers in Immunology"},{"key":"10.7717\/peerj.20329\/ref-18","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ejpb.2016.01.005","article-title":"N-glycosylation heterogeneity and the influence on structure, function and pharmacokinetics of monoclonal antibodies and Fc fusion proteins","volume":"100","author":"Higel","year":"2016","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"key":"10.7717\/peerj.20329\/ref-19","doi-asserted-by":"publisher","first-page":"e4021","DOI":"10.7717\/peerj.4021","article-title":"Generation and characterization of cross neutralizing human monoclonal antibody against 4 serotypes of dengue virus without enhancing activity","volume":"5","author":"Injampa","year":"2017","journal-title":"PeerJ"},{"key":"10.7717\/peerj.20329\/ref-20","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/glycob\/cwaa018","article-title":"Understanding the role of antibody glycosylation through the lens of severe viral and bacterial diseases","volume":"30","author":"Irvine","year":"2020","journal-title":"Glycobiology"},{"key":"10.7717\/peerj.20329\/ref-21","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jviromet.2009.10.026","article-title":"A simple assay system for infection-enhancing and -neutralizing antibodies to dengue type 2 virus using layers of semi-adherent K562 cells","volume":"163","author":"Konishi","year":"2010","journal-title":"Journal of Virological Methods"},{"key":"10.7717\/peerj.20329\/ref-22","doi-asserted-by":"publisher","first-page":"198278","DOI":"10.1016\/j.virusres.2020.198278","article-title":"A potent neutralizing mouse monoclonal antibody specific to dengue virus type 1 Mochizuki strain recognized a novel epitope around the N-67 glycan on the envelope protein: a possible explanation of dengue virus evolution regarding the acquisition of N-67 glycan","volume":"294","author":"Kotaki","year":"2021","journal-title":"Virus Research"},{"key":"10.7717\/peerj.20329\/ref-23","doi-asserted-by":"publisher","first-page":"6631","DOI":"10.1128\/JVI.00316-08","article-title":"Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II","volume":"82","author":"Lai","year":"2008","journal-title":"Journal of Virology"},{"key":"10.7717\/peerj.20329\/ref-24","doi-asserted-by":"publisher","first-page":"896","DOI":"10.4161\/mabs.26436","article-title":"Effects of altered FcgammaR binding on antibody pharmacokinetics in cynomolgus monkeys","volume":"5","author":"Leabman","year":"2013","journal-title":"Mabs"},{"key":"10.7717\/peerj.20329\/ref-25","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.chom.2007.09.015","article-title":"Complement protein C1q inhibits antibody-dependent enhancement of flavivirus infection in an IgG subclass-specific manner","volume":"2","author":"Mehlhop","year":"2007","journal-title":"Cell Host & Microbe"},{"key":"10.7717\/peerj.20329\/ref-26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.virol.2009.08.019","article-title":"Complement modulates pathogenesis and antibody-dependent neutralization of West Nile virus infection through a C5-independent mechanism","volume":"393","author":"Mehlhop","year":"2009","journal-title":"Virology"},{"key":"10.7717\/peerj.20329\/ref-27","doi-asserted-by":"publisher","first-page":"580096","DOI":"10.3389\/fcimb.2020.580096","article-title":"Intrinsic ADE: the dark side of antibody dependent enhancement during dengue infection","volume":"10","author":"Narayan","year":"2020","journal-title":"Frontiers in Cellular and Infection Microbiology"},{"key":"10.7717\/peerj.20329\/ref-28","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.bbrc.2014.02.131","article-title":"Antibody germline characterization of cross-neutralizing human IgGs against 4 serotypes of dengue virus","volume":"446","author":"Pitaksajjakul","year":"2014","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.7717\/peerj.20329\/ref-29","doi-asserted-by":"publisher","first-page":"e0155900","DOI":"10.1371\/journal.pone.0155900","article-title":"Synthetic B-cell epitopes eliciting cross-neutralizing antibodies: strategies for future dengue vaccine","volume":"11","author":"Ramanathan","year":"2016","journal-title":"PLOS ONE"},{"key":"10.7717\/peerj.20329\/ref-30","doi-asserted-by":"publisher","first-page":"e0209576","DOI":"10.1371\/journal.pone.0209576","article-title":"Designing antibody against highly conserved region of dengue envelope protein by in silico screening of scFv mutant library","volume":"14","author":"Rathore","year":"2019","journal-title":"PLOS ONE"},{"key":"10.7717\/peerj.20329\/ref-31","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.bjid.2019.10.009","article-title":"Epitope of dengue virus E protein detect human antibodies associated with mild disease: a potential peptide for vaccine development","volume":"24","author":"Sanchez-Burgos","year":"2020","journal-title":"The Brazilian Journal of Infectious Diseases"},{"key":"10.7717\/peerj.20329\/ref-32","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.antiviral.2013.03.018","article-title":"Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection","volume":"98","author":"Sasaki","year":"2013","journal-title":"Antiviral Research"},{"key":"10.7717\/peerj.20329\/ref-33","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.bbrc.2012.06.057","article-title":"Human monoclonal antibodies to neutralize all dengue virus serotypes using lymphocytes from patients at acute phase of the secondary infection","volume":"423","author":"Setthapramote","year":"2012","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.7717\/peerj.20329\/ref-34","doi-asserted-by":"publisher","first-page":"572681","DOI":"10.3389\/fcimb.2020.572681","article-title":"Antibody-dependent enhancement: a challenge for developing a safe dengue vaccine","volume":"10","author":"Shukla","year":"2020","journal-title":"Frontiers in Cellular and Infection Microbiology"},{"key":"10.7717\/peerj.20329\/ref-35","doi-asserted-by":"publisher","first-page":"12233","DOI":"10.1128\/JVI.00247-14","article-title":"Isolation of dengue virus-specific memory B cells with live virus antigen from human subjects following natural infection reveals the presence of diverse novel functional groups of antibody clones","volume":"88","author":"Smith","year":"2014","journal-title":"Journal of Virology"},{"key":"10.7717\/peerj.20329\/ref-36","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.4049\/jimmunol.143.8.2595","article-title":"Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region","volume":"143","author":"Tao","year":"1989","journal-title":"The Journal of Immunology"},{"key":"10.7717\/peerj.20329\/ref-37","doi-asserted-by":"publisher","first-page":"140","DOI":"10.7883\/yoken.JJID.2019.235","article-title":"Human heavy chain antibody genes elicited in thai dengue patients during DENV2 secondary infection","volume":"73","author":"Thammasonthijarern","year":"2020","journal-title":"Japanese Journal of Infectious Diseases"},{"key":"10.7717\/peerj.20329\/ref-38","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.virol.2009.06.037","article-title":"Dengue virus neutralization by human immune sera: role of envelope protein domain III-reactive antibody","volume":"392","author":"Wahala","year":"2009","journal-title":"Virology"},{"key":"10.7717\/peerj.20329\/ref-39","doi-asserted-by":"publisher","first-page":"e0260954","DOI":"10.1371\/journal.pone.0260954","article-title":"Fc-engineered antibodies with immune effector functions completely abolished","volume":"16","author":"Wilkinson","year":"2021","journal-title":"PLOS ONE"},{"key":"10.7717\/peerj.20329\/ref-40","doi-asserted-by":"publisher","first-page":"e1003157","DOI":"10.1371\/journal.ppat.1003157","article-title":"Therapeutic efficacy of antibodies lacking Fcgamma receptor binding against lethal dengue virus infection is due to neutralizing potency and blocking of enhancing antibodies","volume":"9","author":"Williams","year":"2013","journal-title":"PLOS Pathogens"},{"key":"10.7717\/peerj.20329\/ref-41","doi-asserted-by":"publisher","first-page":"6449","DOI":"10.1016\/j.vaccine.2016.11.021","article-title":"Complement-independent dengue virus type 1 infection-enhancing antibody reduces complement-dependent and -independent neutralizing antibody activity","volume":"34","author":"Yamanaka","year":"2016","journal-title":"Vaccine"},{"key":"10.7717\/peerj.20329\/ref-42","doi-asserted-by":"publisher","first-page":"579","DOI":"10.7883\/yoken.JJID.2016.379","article-title":"Dengue-immune humans have higher levels of complement-independent enhancing antibody than complement-dependent neutralizing antibody","volume":"70","author":"Yamanaka","year":"2017","journal-title":"Japanese Journal of Infectious Diseases"},{"key":"10.7717\/peerj.20329\/ref-43","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1128\/JVI.00992-07","article-title":"Infection-enhancing and -neutralizing activities of mouse monoclonal antibodies against dengue type 2 and 4 viruses are controlled by complement levels","volume":"82","author":"Yamanaka","year":"2008","journal-title":"Journal of Virology"}],"container-title":["PeerJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/peerj.com\/articles\/20329.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/20329.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/20329.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/20329.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T08:24:25Z","timestamp":1763540665000},"score":1,"resource":{"primary":{"URL":"https:\/\/peerj.com\/articles\/20329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":43,"alternative-id":["10.7717\/peerj.20329"],"URL":"https:\/\/doi.org\/10.7717\/peerj.20329","archive":["CLOCKSS","LOCKSS","Portico"],"relation":{},"ISSN":["2167-8359"],"issn-type":[{"value":"2167-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"article-number":"e20329"}}